Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Artivion, Inc. Common Stock (NY:AORT)

36.60 -4.05 (-9.96%)
Official Closing Price Updated: 7:00 PM EST, Feb 13, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Artivion, Inc. Common Stock

< Previous 1 2 3 4 5 Next >
News headline image
Artivion (AORT) Stock Trades Down, Here Is Why
Shares of medical device company Artivion (NYSE:AORT) fell 5.8% in the morning session after the company reported mixed fourth-quarter 2025 financial results, with revenues falling short of analyst... 
Via StockStory
News headline image
AORT Q4 Deep Dive: Stent Graft and On-X Growth Offset By Tissue Flatness, Guidance Highlights Pipeline
Medical device company Artivion (NYSE:AORT) missed Wall Street’s revenue expectations in Q4 CY2025, but sales rose 19.2% year on year to $116 million. On the other hand, the company’s full-year revenue... 
Via StockStory
News headline image
Artivion (AORT) Q4 2025 Earnings Call Transcript ↗
Artivion (AORT) Q4 2025 Earnings Call Transcript 
Via The Motley Fool
Topics Earnings
Artivion Inc (NYSE:AORT) Shares Drop on Q4 Revenue Miss Despite Earnings Beat ↗
Via Chartmill
News headline image
Earnings Scheduled For November 6, 2025 ↗
 
Via Benzinga
News headline image
Artivion (NYSE:AORT) Misses Q4 CY2025 Sales Expectations
Medical device company Artivion (NYSE:AORT) fell short of the market’s revenue expectations in Q4 CY2025, but sales rose 19.2% year on year to $116 million. On the other hand, the company’s full-year... 
Via StockStory
News headline image
What To Expect From Artivion’s (AORT) Q4 Earnings
Medical device company Artivion (NYSE:AORT) will be reporting results this Thursday afternoon. Here’s what to look for. 
Via StockStory
Topics Artificial Intelligence World Trade
News headline image
2 Stocks Under $50 to Research Further and 1 We Avoid
Stocks in the $10-50 range offer a sweet spot between affordability and stability as they’re typically more established than penny stocks. But their headline prices don’t guarantee quality, and... 
Via StockStory
News headline image
1 Profitable Stock with Exciting Potential and 2 Facing Headwinds
Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today doesn’t mean it will thrive tomorrow. 
Via StockStory
News headline image
1 Healthcare Stock on Our Watchlist and 2 We Ignore
Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Those leading the charge have not only realized strong financial performance but also... 
Via StockStory
Topics Stocks
News headline image
3 Reasons to Sell AORT and 1 Stock to Buy Instead
What a time it’s been for Artivion. In the past six months alone, the company’s stock price has increased by a massive 47.8%, reaching $45.61 per share. This was partly thanks to its solid quarterly... 
Via StockStory
Topics Supply Chain
News headline image
1 Safe-and-Steady Stock on Our Watchlist and 2 We Avoid
Stability is great, but low-volatility stocks may struggle to deliver market-beating returns over time as they sometimes underperform during bull markets. 
Via StockStory
News headline image
3 Cash-Producing Stocks with Questionable Fundamentals
While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient spending, slowing demand, or weak... 
Via StockStory
Topics Retirement
News headline image
Artivion (AORT) Stock Is Up, What You Need To Know
Shares of medical device company Artivion (NYSE:AORT) jumped 4.6% in the afternoon session after analyst firm Canaccord Genuity reaffirmed its Buy rating and $51.00 price target, pointing to the... 
Via StockStory
Topics Artificial Intelligence Economy
News headline image
3 Russell 2000 Stocks That Concern Us
The Russell 2000 (^RUT) is home to many small-cap stocks, offering investors the chance to uncover hidden gems before the broader market catches on. However, these companies often come with higher... 
Via StockStory
News headline image
Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks Q3 Teardown: Artivion (NYSE:AORT) Vs The Rest
As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q3. Today, we are looking at medical devices & supplies - cardiology,... 
Via StockStory
News headline image
Oscar Health and Artivion Shares Are Soaring, What You Need To Know
A number of stocks jumped in the afternoon session after comments from a key Federal Reserve official bolstered hopes for an interest rate cut. New York Federal Reserve President John Williams stated... 
Via StockStory
Topics Artificial Intelligence Economy Initial Public Offering
News headline image
5 Must-Read Analyst Questions From Artivion’s Q3 Earnings Call
Artivion delivered a Q3 marked by strong revenue growth and a positive market response, as ongoing adoption of its stent grafts and On-X heart valves fueled performance. Management highlighted... 
Via StockStory
Topics Earnings
News headline image
3 Small-Cap Stocks We Approach with Caution
Many small-cap stocks have limited Wall Street coverage, giving savvy investors the chance to act before everyone else catches on. But the flip side is that these businesses have increased downside... 
Via StockStory
News headline image
Gilead Sciences, Moderna, Artivion, Tenet Healthcare, and Charles River Laboratories Stocks Trade Up, What You Need To Know
A number of stocks jumped in the afternoon session after the market experienced a sharp sector rotation, as investors fled growth-oriented technology stocks and piled into value-oriented names amid... 
Via StockStory
Topics Artificial Intelligence Stocks
News headline image
2 Unpopular Stocks That Deserve a Second Chance and 1 Facing Challenges
When Wall Street turns bearish on a stock, it’s worth paying attention. These calls stand out because analysts rarely issue grim ratings on companies for fear their firms will lose out in other... 
Via StockStory
News headline image
AORT Q3 Deep Dive: AMDS and On-X Outperform, Pipeline and Reimbursement Bolster Outlook
Medical device company Artivion (NYSE:AORT) reported Q3 CY2025 results exceeding the market’s revenue expectations, with sales up 18.4% year on year to $113.4 million. The company’s full-year revenue... 
Via StockStory
News headline image
Artivion Stock: A Deep Dive Into Analyst Perspectives (6 Ratings) ↗
 
Via Benzinga
News headline image
Artivion Inc (NYSE:AORT) Reports Q3 2025 Revenue Beat and Steady Earnings ↗
Artivion (AORT) Q3 2025 revenue beat expectations with 18.4% YoY growth, while EPS aligned with estimates. The medical device firm shows strong momentum. 
Via Chartmill
News headline image
Artivion’s (NYSE:AORT) Q3 Sales Top Estimates
Medical device company Artivion (NYSE:AORT) beat Wall Street’s revenue expectations in Q3 CY2025, with sales up 18.4% year on year to $113.4 million. The company’s full-year revenue guidance of $442... 
Via StockStory
News headline image
Artivion (AORT) Reports Q3: Everything You Need To Know Ahead Of Earnings
Medical device company Artivion (NYSE:AORT) will be reporting earnings this Thursday after market hours. Here’s what to expect. 
Via StockStory
Topics Artificial Intelligence
News headline image
3 Healthcare Stocks We Find Risky
From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. But speed bumps such as inventory destockings have persisted in the wake of... 
Via StockStory
Topics Stocks
News headline image
Firing on All Cylinders: Artivion (NYSE:AORT) Q2 Earnings Lead the Way
Wrapping up Q2 earnings, we look at the numbers and key takeaways for the medical devices & supplies - cardiology, neurology, vascular stocks, including Artivion (NYSE:AORT) and its peers. 
Via StockStory
News headline image
3 Reasons to Sell AORT and 1 Stock to Buy Instead
What a fantastic six months it’s been for Artivion. Shares of the company have skyrocketed 78.2%, hitting $41.02. This was partly thanks to its solid quarterly results, and the performance may have... 
Via StockStory
Topics Supply Chain
News headline image
1 High-Flying Stock on Our Buy List and 2 We Find Risky
Expensive stocks typically earn their valuations through superior growth rates that other companies simply can’t match. The flip side though is that these lofty expectations make them particularly... 
Via StockStory
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.